We have investigated the expression and extracellular release of active, recombinant Mycobacterium tuberculosis glutamine synthetase (EC 6.3.1.2), an enzyme that is a potentially important determinant of M. tuberculosis infection and whose extracellular release is correlated with pathogenicity. The M. tuberculosis glutamine synthetase gene encodes a polypeptide of 478 amino acids; 12 such subunits comprise the active enzyme. Northern blot, nuclease S1, and primer extension analyses revealed glutamine synthetase specific transcripts of ϳ1,550 and 1,650 nucleotides produced under low and high nitrogen conditions, respectively. Expression of recombinant M. tuberculosis glutamine synthetase in Escherichia coli YMC21E, a glutamine synthetase deletion mutant, led to transcomplementation of the mutant but not to release of active enzyme. Expression in Mycobacterium smegmatis 1-2c, from the gene's own promoter, resulted in the release of >95% of all recombinant enzyme. No hybrid molecules containing M. tuberculosis and M. smegmatis glutamine synthetase subunits were detected. Native and recombinant exported and intracellular glutamine synthetase molecules were indistinguishable from one another by mass, N-terminal amino acid sequence, antibody reactivity, and enzymatic activity. Since M. tuberculosis glutamine synthetase is similar to other, strictly intracellular, bacterial glutamine synthetases and the DNA sequence upstream of the structural gene does not encode a leader peptide, the information to target the protein for export must be contained in its amino acid sequence and/or conformation.Mycobacterium tuberculosis, a facultative intracellular parasite, is one of the world's most important pathogens, with new cases of pulmonary tuberculosis and deaths numbering many million annually (1). The rising worldwide incidence of tuberculosis and the emergence of multidrug-resistant M. tuberculosis strains underscore the need for a better understanding of the biology of the organism and the development of new approaches to combat tuberculosis (2).We recently identified glutamine synthetase (L-glutamate: ammonia ligase (ADP-forming); EC 6.3.1.2) as one of several potentially important determinants of M. tuberculosis pathogenesis. Glutamine synthetase may influence the ammonia level within the phagosome containing the pathogen in host cells, profoundly altering physiological conditions in the phagosome, and the enzyme may be directly involved in the synthesis of poly-L-glutamic acid/glutamine found in abundance in the cell wall of pathogenic but not nonpathogenic mycobacteria (3). A remarkable finding in our previous study was that M. tuberculosis glutamine synthetase is abundantly secreted by pathogenic mycobacteria but not by nonpathogenic mycobacteria or nonmycobacterial organisms and that it is released into its phagosome in infected human macrophages.To learn more about this vital enzyme and to develop its potential as a target for novel antimycobacterial drugs, we undertook a detailed molecular analysis of the M. tuberc...